INS and metabolic dysfunction-associated steatotic liver disease: We hypothesized that Peptide 2 supplementation improves systemic and local insulin sensitivity, which in turn alleviates pathological cellular features associated with NAFLD, therefore modulating both glucose and lipid metabolism.